Ck-MB/Ctni Fast Test Kit Cardiac Marker Ami Myocardial Damage Poct Analyzer

• Type: IVD Reagent
• After-Sale Service: Online Technical Support
• Certificate: CE
• Specimen: Serum, Plasma, Whole Blood
• Packaging Details: Wrapped in Aluminium Foil Bag, 25 Tests in One Box
• Transport Package: Carton Box
• Model NO.: CK-MB/cTnI Fast Test Kit
• Specification: 25 Tests/Box
• Trademark: Getein
• Origin: Nanjing, Jiangsu, China
• Production Capacity: 1000000 Units/Per Month

Product Description

Product Description

 

CK-MB/cTnI Fast Test Kit
(Immunofluorescence Assay)

Specifications

Product Name	Sapmle	Test Time	Storage Condition	Shelf Life
CK-MB/cTnI Fast Test Kit (Immunofluorescence Assay)	Serum/Plasma/ Whole Blood	10 min	4-30ºC (test cards)	24 months
Test Item	Kit Size	Method	Product Code	Certificate
CK-MB/cTnI	25 Tests/Kit	Immunofluorescence Assay	IF 1012	CE, ISO 13485

Product Description

INTENDED USE:
CK-MB/cTnI Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of CK-MB/cTnI
in serum, plasma or whole blood. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).

About CK-MB/cTnI:

CK-MB: Creatine kinases are dimer isozymes composed of two monomer subunits, CK-M (for skeletal muscle derived) and CK-B (for brain derived), which can form all three combinations of monomers: CK-BB, CK-MM, and CK-MB. BB is found primarily in the brain. Skeletal muscles primarily contain the MM isoform, with trace amount of MB (around 1-4% of total CK activity). Cardiac muscles also contain the MM isoform, but higher amount of MB, typically around 20% of total CK activity. CK-MB is a more sensitive marker of myocardial injury than total CK activity, because it has a lower basal level and a much narrower normal range.
cTnI: Troponin complex consists of three regulatory proteins: T, which connects the troponin complex and tropomyosin (another cardiac muscle regulatory protein); I, which prevents muscle contraction in the absence of calcium; and C, which binds calcium. Cardiac troponin I (MW 22.5 kDa) and the two skeletal muscle isoforms of troponin I have considerable amino acid sequence homology, but cTnI contains an additional N-terminal sequence and is highly specific for myocardia. Clinical studies have demonstrated the release of cTnI into the blood stream within hours following acute myocardial infarctions (AMI) or ischemic damage.
 

Contents

Clinical Application:
1. Aid in the diagnosis and risk classification of ACS
2. Aid in the diagnosis on various myocardial injury
3. Aid in the evaluation of thrombolysis treatment
4. Estimate size of myocardial infarction
5. Detect degree of myocardial injury during surgery

 

Conte
nt

00:12

 

02:4

About us:

Getein Biotech, Inc. (stock code:603387), estal a fully integrated in vitro diagnostic company that researches and develops, manufactures, fibutes a broad range of innovative diagnostic test kits in point-of-care testing (POCT). In July 2017, Geteinn Biotech got listed on the main board of the Shanghai Stock Exchange. With great contribution of our advanced R&D center and 19-year continuous development, Getein Biotech has developed 8 technology platforms, including Point-of-Care Testing (POCT), clinical chemistry, chemiluminescence, hematology, coagulation, urinalysis, molecular diagnostics and raw materials for diagnostic reagents, covering fields of cardiovascular disease, kidney injury, diabetes mellitus, gestation, infectious disease, cancer, etc..

00:12
02:49